Why is Remedium Life falling/rising?

As of 04-Aug, Remedium Lifecare Ltd is experiencing a decline in its stock price, currently at 1.29, which reflects a decrease of 0.02 or 1.53%. The stock has shown a mixed performance recently, with a 1-week return of +2.38% but a significant year-to-date decline of -63.91%. Today's price summary indicates that the stock underperformed its sector by 2.53%, although it is trading above its 5-day, 20-day, and 50-day moving averages. However, it remains below its 100-day and 200-day moving averages. The company has a high Debt to EBITDA ratio of -1.00 times, indicating a low ability to service debt, and it has reported negative results for the last three consecutive quarters, contributing to its poor long-term growth outlook.
In the broader market context, while the Sensex has shown a slight increase of 0.16% over the past week, Remedium Lifecare's performance has been notably worse, with a year-to-date decline that far exceeds the market's overall negative return of -2.34%. The stock's significant drop of -86.73% over the past year highlights its underperformance compared to the benchmark. Despite a rise in investor participation, as evidenced by a 45.8% increase in delivery volume, the company's ongoing financial struggles and negative operating results continue to weigh heavily on its stock price, making it a risky investment.